| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/18/2007 | EP1411970B1 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/18/2007 | EP1401479B1 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 04/18/2007 | EP1395657B1 Receptor for bacillus anthracis toxin |
| 04/18/2007 | EP1379266B1 Modified annexin proteins and prevention and treatment of thrombosis |
| 04/18/2007 | EP1352063B1 Receptor nucleic acids and polypeptides |
| 04/18/2007 | EP1345918B1 1,5 benzothiazepines and their use as antihyperlipidemics |
| 04/18/2007 | EP1335976B1 Modifier of organelle metalbolism |
| 04/18/2007 | EP1334194B1 Imaging, diagnosis and treatment of disease |
| 04/18/2007 | EP1324652B1 Transgenic drosophila melanogaster expressing beta amyloid |
| 04/18/2007 | EP1272642B1 Coffee mannanase |
| 04/18/2007 | EP1248645B1 Novel chimeric proteins and their use |
| 04/18/2007 | EP1192261B1 22025, a novel human cyclic nucleotide phosphodiesterase |
| 04/18/2007 | EP1180368B1 Freeze dried hgf preparations |
| 04/18/2007 | EP1153125B1 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use |
| 04/18/2007 | EP1144010B1 Prevention of chronic graft rejection by a combination of immunotoxins and costimulation blockers |
| 04/18/2007 | EP1079843B1 Use of alfa1beta1 integrin receptor inhibitors and tgf- beta1 inhibitors in the treatment of kidney disease |
| 04/18/2007 | EP1024835B1 J-chain and analogues as epithelial cell targeting conjugates |
| 04/18/2007 | EP1012282B1 Cysteine rich receptors-train |
| 04/18/2007 | EP1007080B1 Formulation for the sustained release of peptide agonists and analogues of GnRH |
| 04/18/2007 | EP1005374B1 Microparticles for delivery of nucleic acid |
| 04/18/2007 | EP1004669B1 Novel differentiation inhibitor |
| 04/18/2007 | EP1002071B1 Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
| 04/18/2007 | EP0960117B1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |
| 04/18/2007 | EP0799242B1 Amphiphilic complexes, method for preparing same and compositions containing such complexes |
| 04/18/2007 | EP0765169B1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 04/18/2007 | EP0669973B2 Biological factors and neural stem cells |
| 04/18/2007 | CN1950518A Compositions and methods for characterizing, regulating, diagnosing, and treating cancer |
| 04/18/2007 | CN1950512A Recombinant perforin, expression and uses thereof |
| 04/18/2007 | CN1950502A Regulation of cardiac contractility and heart failure propensity |
| 04/18/2007 | CN1950397A Therapeutic use of a growth factor, NsG33 |
| 04/18/2007 | CN1950396A 抗真菌肽 Antifungal Peptide |
| 04/18/2007 | CN1950394A Method for inhibiting immune complex formation in a subjetc |
| 04/18/2007 | CN1950393A Novel inhibitors of hepatitis c virus ns3 protease |
| 04/18/2007 | CN1950202A Films comprising a liquid-absorbant inner layer, an antimicrobial material and an impermeable outer layer |
| 04/18/2007 | CN1950106A Synthetic protein as tumor-specific vaccine |
| 04/18/2007 | CN1950105A Polypeptide inducing the secretion of angiopoietin |
| 04/18/2007 | CN1950104A Medicament for the treatment of fungal infections, particularly aspergillosis |
| 04/18/2007 | CN1950103A Methods for preventing or treating bone disorders |
| 04/18/2007 | CN1950102A Modulation of cartilage homeostasis |
| 04/18/2007 | CN1950101A Use of peptidic compounds for the prophylaxis and treatment of chronic headache |
| 04/18/2007 | CN1950100A Multi-component biological transport systems |
| 04/18/2007 | CN1950088A Use of carboxypeptidase G for combating antifolate toxicity |
| 04/18/2007 | CN1948495A Saliva streptococcus 57.I urase gene and its urase |
| 04/18/2007 | CN1948493A Hepatitis B virus vaccine synergistic protein and its gene |
| 04/18/2007 | CN1948492A Human hZNF shgc gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948491A Human hZNF216-iso gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948490A Human hRAB-14 gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948489A Human hTCRrp gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948488A Human hILF-1-iso gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948487A Human ad-ZNF 127 xp gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948486A Human hGPR-iso gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948485A Human hp52-ap gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948477A Preparation method of gene recombination fusion protein PFK |
| 04/18/2007 | CN1948472A High efficiency expression method of earthworm kinase single component F-II in yeast and product |
| 04/18/2007 | CN1948342A HLA-A2 restriction epi polypeptide originated from post selection cancer gene hRabj and its application |
| 04/18/2007 | CN1948340A Protein of interreaction with karyomitosis primary activator protein kinase p38 and its coding gene and application |
| 04/18/2007 | CN1948337A Preparation method of wheat germ agglutinin and its application in inhibiting mammary gland cancer activity |
| 04/18/2007 | CN1948333A New hPEBP4 protein source HLA-A2 limiting epi-polypeptide and its application |
| 04/18/2007 | CN1947792A Method for preparing active protein composition type nano-selenium and its liquid phase storage tech. |
| 04/18/2007 | CN1947702A Lipid carrier and method of preparing the same |
| 04/18/2007 | CN1311238C Hypotensors |
| 04/18/2007 | CN1311077C Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 04/18/2007 | CN1311076C Method for producing recombinaton urokinase |
| 04/18/2007 | CN1310949C Bifunctional chimeric profein possessing inhibiting leucocyte function and thrombin activity |
| 04/18/2007 | CN1310948C Modified peptides as therapeutic agents |
| 04/18/2007 | CN1310947C Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use as the rapentics |
| 04/18/2007 | CN1310946C Method for preparing injection collagen, and product and use thereof |
| 04/18/2007 | CN1310944C Novel human keratinocyte growth factor mutant |
| 04/18/2007 | CN1310942C Suppressor gene |
| 04/18/2007 | CN1310679C Method of achieving persistent transgene expression |
| 04/18/2007 | CN1310678C Administration of agents for the treatment of inflammation |
| 04/18/2007 | CN1310675C TNF-alpha converting enzyme |
| 04/18/2007 | CN1310674C Medicinal composition for treating serious acute respiratory syndrome |
| 04/18/2007 | CN1310673C Composition of multiple scattered mixture contg.polypeptide and its pharm compsn. |
| 04/18/2007 | CN1310672C Osteogenis oligopeptide as blood-formation stimulation articles |
| 04/18/2007 | CN1310671C Sustained-release compositions for injection and process for producing the same |
| 04/17/2007 | USRE39571 Identifier tag is a microchip that is pre-encoded or encodable with information that is related back to a detector when the identifier tag is pulsed with electromagnetic radiation, drug discovery |
| 04/17/2007 | US7205435 Type B botulism toxin inhibitors |
| 04/17/2007 | US7205398 For enhancing an immune response in an animal; for therapy and prophylaxis of infectious diseases or cancer |
| 04/17/2007 | US7205397 Modulatory polypeptide; for use in the treatment of bone disorders |
| 04/17/2007 | US7205392 Synergistic mixture of glycoprotein and angiogenesis inhibitor |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205385 Polymerization method for the synthesis of polypeptide imaging agents |
| 04/17/2007 | US7205384 Process for preparing peptidyl heterocyclic ketone derivatives |
| 04/17/2007 | US7205383 Peptide ligands of leukocyte integrins |
| 04/17/2007 | US7205381 Modulating interferons |
| 04/17/2007 | US7205378 therapeutic agent is reversibly immobilized on polymer matrix using ionic complexation between latent carboxylic groups present on the lactone bearing polymer matrix and a cationic group on the therapeutic agent; drug delivery |
| 04/17/2007 | US7205336 β-secretase inhibitors |
| 04/17/2007 | US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide |
| 04/17/2007 | US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives |
| 04/17/2007 | US7205281 Process for the synchronization of ovulation for timed breeding without heat detection |
| 04/17/2007 | US7205280 Methods of suppressing microglial activation |
| 04/17/2007 | US7205279 Pharmaceutical compositions |
| 04/17/2007 | US7205278 Introducing one or more cysteine residues into a polypeptide which permit the stabilization of the polypeptide by formation of at least one bond, preferably a disulfide bond, between different domains of the polypeptide. |
| 04/17/2007 | US7205277 Zinc-free and low-zinc insulin preparations having improved stability |
| 04/17/2007 | US7205276 Zinc-free and low-zinc insulin preparations having improved stability |
| 04/17/2007 | US7205275 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/17/2007 | US7205274 Hybrid peptides modulate the immune response |
| 04/17/2007 | US7205272 CFTR polypeptides, fragments thereof and methods of use to overcome biosynthetic misprocessing |
| 04/17/2007 | US7205144 Nucleotide sequences encoding a sensor kinase, citA, from Corynebacterium glutamicum |